• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Petplan Acquired By Global Private Equity Firm Warburg Pincus

Share:

October 7, 2019

Petplan, a leading pet health insurance provider in North America, today announced that the company has been acquired by Warburg Pincus, a global private equity firm focused on growth investing. The acquisition will provide Petplan with access to significant capital and resources to drive meaningful growth. Financial terms of the transaction were not disclosed.

Petplan, headquartered in Newtown Square, Pennsylvania, provides pet health insurance to over 200,000 customers in the U.S. and Canada. Under the leadership of CEO, Paul Guyardo, Petplan has experienced substantial growth, including the recent milestone of reaching 200,000 active subscribers. In the past year, total Petplan subscriptions have grown by nearly 15 percent – the fastest and most significant growth since 2015.

“This investment is a game changer for Petplan. It enables us to catapult the product innovation and customer experience that our company was founded upon and introduce the very best pet health insurance to millions of pet parents in North America,” said Paul Guyardo, CEO, Petplan. “We’re thrilled to be working with Warburg Pincus and the multitude of resources the firm provides.”

“As a long-term investor in the insurance sector, we see incredible potential in Petplan given its leading position in an underpenetrated and growing market,” said Jeff Stein, Managing Director, Warburg Pincus. “We are excited to partner with Paul and his management team to help drive the Company’s next phase of growth.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

As part of the acquisition, John Giannuzzi will join as Chairman of the Board for Petplan. Mr. Giannuzzi is the Co-Founder and Managing General Partner of Sherbrooke Capital, a growth capital private equity firm focused on investing in emerging consumer companies.

According to the American Pet Products Association, Americans will spend more than $18 billion on vet care this year alone1. Rising healthcare costs, combined with an increased awareness of pet insurance, has created significant market potential. With sixty-seven percent of U.S. households owning a pet2, only 2% of these pets are insured3, compared to the 25%-30% pet insurance levels found across Europe4. Pet insurance can save pet owners up to 90% on trips to the vet’s office for unexpected accidents, injuries and illnesses.

Warburg Pincus has invested over $13 billion across the full spectrum of the financial services landscape, including insurance, banking, asset management, specialty finance, payments, and transaction processing. Investments in insurance include, Foundation Risk Partners, SCM Insurance, McGill & Partners, Arch Capital, RenaissanceRe, and Aeolus Re.

Cozen O’Connor served as the legal advisor to Petplan and Wachtell, Lipton, Rosen & Katz served as the legal advisor to Warburg Pincus.

1 Pet Industry Market Size & Ownership Statistics, American Pet Products Association
2 American Pet Products Association (APPA) National Pet Owners Survey (2019-2020)
3 North American Pet Health Insurance Association (NAPHIA)
4 Canadian Animal Health Institute, Market Research Group

Date: October 07, 2019

Source: PR Newswire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sinopharm buys 60 pct device distributor for $765 mlnSinopharm buys 60 pct device distributor for $765 mln
  • Biogen, Broad Institute of MIT and Harvard, Partners HealthCare Launch Consortium to Build and Share a COVID-19 BiobankBiogen, Broad Institute of MIT and Harvard, Partners HealthCare Launch Consortium to Build and Share a COVID-19 Biobank
  • Shareholders approve Acquisition of SalvaRx LimitedShareholders approve Acquisition of SalvaRx Limited
  • WCG Acquires PharmaSeek, LLCWCG Acquires PharmaSeek, LLC
  • Temperature-Controlled Packaging Solutions in Healthcare Market Future Prospects 2026Temperature-Controlled Packaging Solutions in Healthcare Market Future Prospects 2026
  • Confluent Announces Significant Investment in ATI Nitinol Melt Expansionconfluent Becomes ATI’s Fulfillment Partner for Medical NitinolConfluent Announces Significant Investment in ATI Nitinol Melt Expansionconfluent Becomes ATI’s Fulfillment Partner for Medical Nitinol
  • Digital Health’s Role in Meeting the Customer’s ExpectationsDigital Health’s Role in Meeting the Customer’s Expectations
  • Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsAmpio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications